Press

Global Wellness Strategies and Cannvalate AU Sign Revolutionary Psychedelic Deal

Jul 19 • 3 min read

Quick Take: Global Wellness Strategies has signed a binding letter of intent with Cannvalate to acquire their wholly owned subsidiary, Shanti Therapeutics. Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) is pleased to announce it has signed a binding letter of intent (“BLOI”) on July 12, 2021 with Cannvalate Pty Ltd (“CVL”) based in Australia to…

Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer

Jul 16 • 3 min read

Quick Take: Nova Mentis Life Science has appointed a new Chief Science Officer, Dr. Stephen Glazer Nova Mentis Life Science Corp. (CSE: NOVA), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders, is pleased to announce the appointment of Dr. Stephen Glazer as Director, Chief Science Officer. “We’re proud to welcome Dr….

Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc

Jul 15 • 4 min read

Quick Take: Red Light Holland’s expected merger partner Creso Pharma Ltd. has announced the acquisition of Halucenex Life Sciences Ltd. Red Light Holland Corp. (CSE: TRIP), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce…

Awakn Life Sciences Initiates Research Program to Further Develop Ketamine-Assisted Therapies for Treating Addiction

Jul 15 • 3 min read

Quick Take: Awkn has announced that they will be starting a new program to study and demonstrate ketamine’s effectiveness in treating multiple addictions. Awakn Life Sciences Corp. (NEO: AWKN), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better treat addiction, announced that it will undertake a program of clinical research designed…

Clearmind Announces Changes To Senior Management As It Accelerates Development Of Its IP Portfolio

Jul 14 • 3 min read

Quick Take: Clearmind has appointed four new members to its senior management team, including CEO, COO, CFO, and special advisor for innovation. Clearmind Medicine Inc. (CSE: CMND), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, is pleased to announce changes to its…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441